Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

The rest of the world is not following the US government’s dangerous path, and will stick with the technology that helped the ...

Scientists say HHS’s decision to stop investing in mRNA vaccine research is another sign of the growing politicization of ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...

A detailed picture of what happens when DNA transcription is paused early in the process has been obtained by structural ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

A new study, led by researchers at Children's Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA that are missing in pediatric high-grade glioma tumors but not in normal brain ...

Fifteen years ago, immunologist Dusan Bogunovic stumbled across a handful of patients whose bodies played by different rules.

Shares of the biotech Moderna were up on Wednesday, as the Trump administration’s shifting position on messenger RNA-based ...

One of the more notable successes of President Donald Trump’s first term was how the administration was able to develop ...

New messenger RNA vaccines to fight the coronavirus are based on a technology that could transform medicine. Next up: sickle cell and HIV. On December 23, as part of a publicity push to encourage ...